日间过度嗜睡与非痴呆老年人纵向β-淀粉样蛋白沉积的关联
基于梅奥诊所老龄化研究的前瞻性分析,纳入283例70岁及以上无痴呆老年人,基线日间过度嗜睡(EDS)定义为Epworth嗜睡量表评分至少10分,随访至少2次PiB-PET。基线EDS与前扣带、后扣带-楔前叶及顶叶区域β-淀粉样蛋白(Aβ)纵向沉积增加相关。
要点
- 基线EDS与前扣带、后扣带-楔前叶及顶叶区域Aβ纵向沉积增加相关。
- 在基线全局PiB阳性的参与者中,EDS与Aβ沉积的关联更强。
- 作者认为有EDS者可能更易发生阿尔茨海默病相关病理改变。
核心结论
- 基线EDS与无痴呆老年人纵向Aβ沉积增加相关,提示有EDS者可能更易发生阿尔茨海默病相关病理改变。
- 作者认为,早期识别EDS并治疗潜在睡眠障碍可能减少这一脆弱人群的Aβ沉积。
研究设计与样本
- 梅奥诊所老龄化研究(明尼苏达州奥姆斯特德县)的前瞻性分析,2900名参与者中2172人(74.9%)同意接受碳11标记匹兹堡化合物B正电子发射断层扫描(PiB-PET)。
- 纳入283例70岁及以上无痴呆、完成基线嗜睡问卷且2009年1月1日至2016年7月31日间至少完成2次连续PiB-PET的参与者,排除45例(13.7%)合并神经系统疾病者。
主要发现
- 283例参与者平均(SD)年龄77.1(4.8)岁,204例(72.1%)为男性,79例(27.9%)为女性,63例(22.3%)有EDS。
- 基线EDS与前扣带Aβ沉积增加相关(B系数=0.031;95%CI,0.001-0.061;P=0.04)。
- 基线EDS与后扣带-楔前叶Aβ沉积增加相关(B系数=0.038;95%CI,0.006-0.069;P=0.02)。
- 基线EDS与顶叶Aβ沉积增加相关(B系数=0.033;95%CI,0.001-0.065;P=0.04)。
- 在基线全局PiB阳性者中,EDS与前扣带(B系数=0.065;95%CI,0.010-0.118;P=0.02)及扣带-楔前叶(B系数=0.068;95%CI,0.009-0.126;P=0.02)Aβ沉积的关联更强。
关键数值与推荐
- EDS定义为Epworth嗜睡量表评分至少10分。
- Aβ易感区域包括前额叶、前扣带、后扣带-楔前叶和顶叶,以2次连续扫描间Aβ水平差值(ΔPiB)衡量。
- 全局PiB阳性定义为标准化摄取比值≥1.4。
- 多因素线性回归模型校正基线年龄、性别、载脂蛋白E ε4等位基因、教育水平、基线PiB摄取、全局PiB阳性、体力活动、心血管合并症、睡眠时间减少、睡眠呼吸症状、抑郁及扫描间隔。
临床怎么用
- 作者认为,早期识别有EDS的患者并治疗潜在睡眠障碍可能减少这一脆弱人群的Aβ沉积。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Aging is associated with excessive daytime sleepiness (EDS), which has been linked to cognitive decline in the elderly. However, whether EDS is associated with the pathologic processes of Alzheimer disease remains unclear. OBJECTIVE: To investigate whether EDS at baseline is associated with a longitudinal increase in regional β-amyloid (Aβ) accumulation in a cohort of elderly individuals without dementia. DESIGN, SETTING, AND PARTICIPANTS: This prospective analysis included participants enrolled in the Mayo Clinic Study of Aging, a longitudinal population-based study in Olmsted County, Minnesota. Of 2900 participants, 2172 (74.9%) agreed to undergo carbon 11-labeled Pittsburgh compound B positron emission tomography (PiB-PET). We included 283 participants 70 years or older without dementia who completed surveys assessing sleepiness at baseline and had at least 2 consecutive PiB-PET scans from January 1, 2009, through July 31, 2016, after excluding 45 (13.7%) who had a comorbid neurologic disorder. MAIN OUTCOMES AND MEASURES: Excessive daytime sleepiness was defined as an Epworth Sleepiness Scale score of at least 10. The difference in Aβ levels between the 2 consecutive scans (ΔPiB) in Aβ-susceptible regions (prefrontal, anterior cingulate, posterior cingulate-precuneus, and parietal) was determined. Multiple linear regression models were fit to explore associations between baseline EDS and ΔPiB while adjusting for baseline age, sex, presence of the apolipoprotein E ε4 allele, educational level, baseline PiB uptake, global PiB positivity (standardized uptake value ratio ≥1.4), physical activity, cardiovascular comorbidities (obesity, hypertension, hyperlipidemia, and diabetes), reduced sleep duration, respiratory symptoms during sleep, depression, and interval between scans. RESULTS: Of the initial 283 participants, mean (SD) age was 77.1 (4.8) years; 204 (72.1%) were men and 79 (27.9%) were women. Sixty-three participants (22.3%) had EDS. Baseline EDS was significantly associated with increased regional Aβ accumulation in the anterior cingulate (B coefficient = 0.031; 95% CI, 0.001-0.061; P = .04), posterior cingulate-precuneus (B coefficient = 0.038; 95% CI, 0.006-0.069; P = .02), and parietal (B coefficient = 0.033; 95% CI, 0.001-0.065; P = .04) regions. Association of EDS with longitudinal Aβ accumulation was stronger in participants with baseline global PiB positivity in the anterior cingulate (B coefficient = 0.065; 95% CI, 0.010-0.118; P = .02) and cingulate-precuneus (B coefficient = 0.068; 95% CI, 0.009-0.126; P = .02) regions. CONCLUSIONS AND RELEVANCE: Baseline EDS was associated with increased longitudinal Aβ accumulation in elderly persons without dementia, suggesting that those with EDS may be more vulnerable to pathologic changes associated with Alzheimer disease. Further work is needed to elucidate whether EDS is a clinical marker of greater sleep instability, synaptic or network overload, or neurodegeneration of wakefulness-promoting centers. Early identification of patients with EDS and treatment of underlying sleep disorders could reduce Aβ accumulation in this vulnerable group.
引用
- Carvalho DZ, St Louis EK, Knopman DS, et al. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia. JAMA Neurol. 2018. PMID: 29532057. doi:10.1001/jamaneurol.2018.0049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。